SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-13-043022
Filing Date
2013-08-06
Accepted
2013-08-06 12:51:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 113449
  Complete submission text file 0000000000-13-043022.txt   157430
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 5143323222
NYMOX PHARMACEUTICAL CORP (Filed for) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2835 In Vitro & In Vivo Diagnostic Substances